Business
ZINZINO AB (PUBL.): ZINZINO INITIATES NEGOTIATIONS FOR PART OWNERSHIP IN ANDORRA-BASED XION INTERNATIONAL GROUP FOR FURTHER DEVELOPMENT OF PROPRIETARY OMEGA-3 OIL AND SPIRULINA
Zinzino has initiated a process to acquire 35% of Xion International Group in order to form a joint venture to produce algae using bioreactors. The expanded collaboration is another strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales.
About this update from Zinzino Ab Class B
[{"type":"text","content":"GOTHENBURG, Sweden, July 14, 2025 /PRNewswire/ -- Zinzino has initiated a process to acquire 35% of Xion International Group in order to form a joint venture to produce algae using bioreactors. The expanded collaboration is another strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales.","length":461,"tagName":"p"},{"type":"text","content":"Xion is an innovative, proprietary production company based in Spain that has developed one of the world's first high-tech photobioreactor systems for producing the nutrient-dense microalgae spirulina. Xion's pioneering, award-winning technology, combined with a cultivation method based on nature's own principles, sets a new standard for sustainable, efficient, and clean production and creates great opportunities for large-scale cultivation and production of all types of photosynthetic, plant-based algae. Zinzino has initiated negotiations for future co-ownership in Xion to develop the cultivation method and production of microalgae and secure a future sustainable raw material supply of omega-3 for the company's main product, BalanceOil+, a polyphenol-rich, omega-balancing dietary supplement. This is a very important, strategic initiative to meet the increased need for the product arising from Zinzino's global expansion and high sales growth.","length":976,"tagName":"p"},{"type":"text","content":"The operations in Xion are currently conducted on a smaller scale, where most of the production goes to Zinzino's existing, spirulina-based products that have been added through the acquisition of Xelliss in 2024. Xion has a turnover of approximately EUR 1.3 million. A future co-ownership gives Zinzino access to Xion's IP rights, opening up opportunities to further develop and increase brand protection for Zinzino's product portfolio. The aim is to negotiate with the sellers and sign an agreement to acquire parts of Xion's business, which is expected to be finalised in the second half of 2025. A visionary mindset, tech-first perspective, test-based nutrition that nourishes at the cellular level, and a strong position to capitalise on current trends lay the foundation for the collaboration...